Metabolic syndrome: a clinical and molecular perspective.
about
SIRT2 as a Therapeutic Target for Age-Related DisordersPlasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery diseaseEffects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic miceReversal of high dietary fructose-induced PPARalpha suppression by oral administration of lipoxygenase/cyclooxygenase inhibitorsNew obesity classification criteria as a tool for bariatric surgery indicationRegulation of adipocyte autophagy--the potential anti-obesity mechanism of high density lipoprotein and ApolipoproteinA-IInteractions between the microbiota and the immune system"The NET Outcome": Are Neutrophil Extracellular Traps of Any Relevance to the Pathophysiology of Autoimmune Disorders in Childhood?The role of fatty acid binding proteins in metabolic syndrome and atherosclerosisRegulation of the gene encoding GPR40, a fatty acid receptor expressed selectively in pancreatic beta cellsSpatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cellsFoxO1 mediates insulin-dependent regulation of hepatic VLDL production in miceMicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasisObesity during growth in Switzerland: role of early socio-cultural factors favouring sedentary activities.Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.The role of the small intestine in the development of dietary fat-induced obesity and insulin resistance in C57BL/6J mice.Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism--the GENOBIN study.Role of oxidative stress in pathogenesis of metabolic syndromeDisruption of protein kinase A in mice enhances healthy aging.Potential Role of Lipometabolism-Related MicroRNAs in Peripheral Blood Mononuclear Cells as Biomarkers for Coronary Artery Disease.Prevalence of Metabolic Syndrome in Liver Transplant Recipients in IranCentral obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.Differences in outcome between obese and nonobese patients following severe blunt trauma are not consistent with an early inflammatory genomic response.Prevention Mechanism of 2,3,5,4'-Tetrahydroxy-stilbene-2-O-β-D-glucoside on Lipid Accumulation in Steatosis Hepatic L-02 CellGenetic ablation of calcium-independent phospholipase A2gamma prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation.Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity.Sensitivity of various body indices and visceral adiposity index in predicting metabolic syndrome among Chinese patients with adult growth hormone deficiency.Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.Effects of whole and refined grains in a weight-loss diet on markers of metabolic syndrome in individuals with increased waist circumference: a randomized controlled-feeding trialGestational protein restriction impairs insulin-regulated glucose transport mechanisms in gastrocnemius muscles of adult male offspring.Gene-nutrient interactions with dietary fat modulate the association between genetic variation of the ACSL1 gene and metabolic syndromePositron emission tomography probe demonstrates a striking concentration of ribose salvage in the liver.Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trialIntersection between metabolic dysfunction, high fat diet consumption, and brain aging.Prevalence of metabolic syndrome: association with risk factors and cardiovascular complications in an urban populationOxidatively modified forms of albumin in patients with risk factors of metabolic syndromeMicroRNAs in cardiometabolic disease.Antidiabetic Effect of Methanolic Extract from Berberis julianae Schneid. via Activation of AMP-Activated Protein Kinase in Type 2 Diabetic Mice.Particulate air pollution, metabolic syndrome, and heart rate variability: the multi-ethnic study of atherosclerosis (MESA).Metabolic syndrome as a risk factor for neurological disorders.
P2860
Q21129286-6E0A1048-7064-412F-A29B-F9B77BE196B6Q21245693-8433EDFA-88E8-4ED2-8366-5BD26B9AC97AQ24302828-EEFE724A-CF97-45B2-A006-C5823E76E6E6Q24814568-AF9E24C2-9DBA-4758-BA3F-D9F47EAE08E2Q26774656-92B916F8-409D-45D7-80C9-E493E82768F7Q26859684-F7C984E6-1067-411B-88C6-D7CD9D8A494FQ27028155-FC230AFE-3EA1-428F-8258-A01D7736BEAFQ28070285-4AFCD1D9-4BB1-4E5E-A6CB-6EEFBD2BD947Q28271189-6B8B1E37-090A-46A9-9711-F7ECB218789CQ28303815-EC6555B8-F27D-4841-BB25-F45A794C9BA7Q28506688-3162D635-5D6E-49B6-AC53-92D02AC04DDDQ28507512-7FA2705E-E03E-4BAF-BBA4-E472508FD5B2Q28509140-3FD07CFC-A28E-491F-A665-10AADDF287CFQ30358345-3F3BFC14-E45A-41BC-9CCB-E8FD4CAA8EB5Q30429027-14509585-A750-4429-B3E5-ECA851982D88Q33331801-100E8D67-AE9C-48E4-91EF-73ACCFC94467Q33350242-D37760FA-DC97-4CE3-B17E-6E6B4FF4DA29Q33361889-1D2C179F-0EE3-4C6A-9B13-94E734CF10E2Q33470238-9CBE7E1F-E7AA-467E-B3C5-9A25159D9A64Q33567332-02AFA2C7-867D-4D6E-B7C1-B164F6A2743AQ33577480-5A2DB3CE-7FD8-4F0C-82C5-6B61E4D221F0Q33589372-65215FAF-2018-4BF4-8756-04B166E4B3ECQ33640251-86EF54BD-2751-461C-9171-7B9C5CA94C60Q33647291-9AA807FA-9596-4AD3-89BA-C7ED9FAA0646Q33684502-9DC9C7CD-7C69-4BC0-9379-91E305805C5CQ33707961-A3AB338B-8FA7-4F78-B6A7-46CBCF37B62EQ33726052-4C7C8FE7-1C27-47AE-8AE8-06B097531BE3Q33865096-7E51EC40-6D64-45F0-A32D-1048637642BCQ33892659-BD99D275-FFB7-4A27-824D-7FED4145803DQ33901226-6BAD0AB8-2DF2-4206-9C58-5C4E6987EF53Q33902018-D3B65B73-CD63-43B2-87D0-45D73735D736Q33925802-B1491F5C-DFA1-4580-8ACF-3769C3E3014EQ33932584-8B880A14-B7F0-43CC-B7A5-40E3567576A5Q34020532-FA4DCE1E-289D-499D-90A6-0EDA9AA05DB2Q34121763-AB9B60A6-BCA1-476D-9BEB-5757AF43B327Q34157415-47BFD443-F10F-4A89-9005-5B471A6E4A03Q34175509-F0FF7BD1-9D9D-40DD-BBC3-1ADC7E3EAFC3Q34203330-22408ACF-20B5-4F0C-90D6-EDD443996A51Q34215639-D5CA03DB-4D50-4034-93C8-2B4B873FA710Q34224030-C7E7D525-8E02-4CC8-969D-5434B499A49A
P2860
Metabolic syndrome: a clinical and molecular perspective.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Metabolic syndrome: a clinical and molecular perspective.
@ast
Metabolic syndrome: a clinical and molecular perspective.
@en
type
label
Metabolic syndrome: a clinical and molecular perspective.
@ast
Metabolic syndrome: a clinical and molecular perspective.
@en
prefLabel
Metabolic syndrome: a clinical and molecular perspective.
@ast
Metabolic syndrome: a clinical and molecular perspective.
@en
P1476
Metabolic syndrome: a clinical and molecular perspective.
@en
P2093
David E Moller
Keith D Kaufman
P356
10.1146/ANNUREV.MED.56.082103.104751
P577
2005-01-01T00:00:00Z